BioPlus Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIOS research report →
About the company
Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction.
- CEO
- R. Ross Haghighat
- IPO
- 2022
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $209.07M
- P/E
- 1249.89
- P/S
- 0.00
- P/B
- 28.94
- EV/EBITDA
- -182.69
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 2.33%
- ROIC
- -0.49%
- Revenue
- $0 · 0.00%
- Net Income
- $5.16M · 3375823.30%
- EPS
- $0.01 · 138.74%
- Op Income
- $-1,171,000
- FCF YoY
- -81798.51%
- 52W High
- $11.68
- 52W Low
- $10.12
- 50D MA
- $10.77
- 200D MA
- $10.55
- Beta
- 0.00
- Avg Volume
- 35.93K
Get TickerSpark's AI analysis on BIOS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 5, 23 | BioPlus Sponsor LLC | other | 5,749,999 |
| Jun 5, 23 | BioPlus Sponsor LLC | other | 5,749,999 |
| Dec 7, 21 | BioPlus Sponsor LLC | other | 380,000 |
| Dec 7, 21 | BioPlus Sponsor LLC | other | 0 |
| Dec 2, 21 | BioPlus Sponsor LLC | other | 5,175,000 |
| Dec 2, 21 | Giovannetti Glen | other | 0 |
| Dec 2, 21 | SHERWIN STEPHEN A | other | 0 |
| Dec 2, 21 | LANGE LOUIS G | other | 0 |
| Dec 2, 21 | Cross Shawn | other | 0 |
| Dec 2, 21 | Eastman Ronald W | other | 0 |
Our BIOS coverage
Recent articles, reports, and earnings notes.
No research on BIOS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIOS report →Similar companies
Peers in the same neighborhood.